Page last updated: 2024-09-03

sch 23982 and bucladesine

sch 23982 has been researched along with bucladesine in 1 studies

Compound Research Comparison

Studies (sch 23982)	Trials (sch 23982)	Recent Studies (post-2010) (sch 23982)	Studies (bucladesine)	Trials (bucladesine)	Recent Studies (post-2010) (bucladesine)
87	0	0	9,775	13	210

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gardner, N; Humblot, N; Kimura, K; Olde, B; Sidhu, A	1

Other Studies

1 other study(ies) available for sch 23982 and bucladesine

Article	Year
Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells. Neuroscience, 1999, Volume: 91, Issue:2 Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Bucladesine; Cell Division; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Neuroblastoma; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, Dopamine D1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured	1999

Article

Year

Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.

Neuroscience, 1999, Volume: 91, Issue:2

Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Bucladesine; Cell Division; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Neuroblastoma; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, Dopamine D1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1999